Connective tissue disease in pregnancy

Clinical Medicine, Journal of the Royal College of Physicians of London

Volumn 13, Issue 6, 2013, Pages 580-584

  Ateka Barrutia, Oier ^a   Nelson Piercy, Catherine ^b  

^a JOHN RADCLIFFE HOSPITAL   (United Kingdom)

^b GUY'S AND ST THOMAS' NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

Connective tissue disease; Management; Medications; Pre pregnancy counselling; Pregnancy

Indexed keywords

ABATACEPT; ACETYLSALICYLIC ACID; AZATHIOPRINE; BCG VACCINE; BELIMUMAB; COLCHICINE; CYCLOPHOSPHAMIDE; CYCLOSPORIN; CYCLOSPORIN A; DIPYRIDAMOLE; ENDOTHELIN RECEPTOR ANTAGONIST; FOLIC ACID; HYDROCORTISONE; HYDROXYCHLOROQUINE; IMMUNOGLOBULIN; LEFLUNOMIDE; METHOTREXATE; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; NONSTEROID ANTIINFLAMMATORY AGENT; PHOSPHODIESTERASE V INHIBITOR; PHOSPHOLIPID ANTIBODY; PREDNISOLONE; PREDNISONE; RECOMBINANT INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; SALAZOSULFAPYRIDINE; TACROLIMUS; TOCILIZUMAB; UNINDEXED DRUG; USTEKINUMAB;

ANTIPHOSPHOLIPID SYNDROME; ARTICLE; BREAST FEEDING; CONGENITAL HEART BLOCK; CONNECTIVE TISSUE DISEASE; DISEASE ACTIVITY; ERYTHROCYTE SEDIMENTATION RATE; GESTATIONAL AGE; GROWTH RETARDATION; HUMAN; KIDNEY BLOOD FLOW; LONG TERM CARE; MATERNAL CARE; NEONATAL LUPUS SYNDROME; NEWBORN DISEASE; PATIENT COUNSELING; PREGNANCY; PREGNANCY OUTCOME; PREMATURE LABOR; PROTEINURIA; PUERPERIUM; RHEUMATOID ARTHRITIS; RISK ASSESSMENT; SYSTEMIC LUPUS ERYTHEMATOSUS; SYSTEMIC SCLEROSIS; THIRD TRIMESTER PREGNANCY; VASCULITIS;

CONNECTIVE TISSUE DISEASE; MANAGEMENT; MEDICATIONS; PRE-PREGNANCY COUNSELLING; PREGNANCY;

CONNECTIVE TISSUE DISEASES; DISEASE MANAGEMENT; FEMALE; HUMANS; MORBIDITY; PREGNANCY; PREGNANCY COMPLICATIONS; PREGNANCY OUTCOME; WORLD HEALTH;

EID: 84890897936     PISSN: 14702118     EISSN: 14734893     Source Type: Journal    
DOI: 10.7861/clinmedicine.13-6-580     Document Type: Article

References (31)

1. Silva CA, Bonfa E, Ostensen M. Maintenance of fertility in patients with rheumatic diseases needing anti-inflammatory and immunosuppressive drugs. Arthritis Care Res 2010;62:1682-90.
2. Bellver J, Pellicer A. Ovarian stimulation for ovulation induction and in vitro fertilization in patients with systemic lupus erythematosus and antiphospholipid syndrome. Fertil Steril 2009;92:1803-10.
3. Andrade RM, McGwin Jr G, Alarcon GS et al. Predictors of postpartum damage accrual in systemic lupus erythematosus: data from LUMINA, a multiethnic US cohort (XXXVIII). Rheumatology 2006;45:1380-4.
4. Ruiz-Irastorza G, Khamashta MA. Lupus and pregnancy: integrating clues from the bench and bedside. Eur J Clin Invest 2011;41:672-8.
5. Clowse ME, Witter FR, Magder LC, Petri M. The impact of increased lupus activity on obstetrical outcomes. Arthritis Rheum 2005;52:514-22.
6. Imbasciati E, Tincani A, Gregorini G et al. Pregnancy in women with pre-existing lupus nephritis: predictors of fetal and maternal outcome. Nephrol Dial Transplant 2009;24:519-25.
7. Ruiz-Irastorza G, Ramos-Casals M, Brito-Zeron P, Khamashta MA. Clinical efficacy and side effects of antimalarials in systemic lupus erythematosus: a systematic review. Ann Rheum Dis 2010;69:20-8.
8. Bramham K, Hunt BJ, Germain S et al. Pregnancy outcomes in systemic lupus erythematosus with and without previous nephritis. J Rheumatol 2011;38:1906-13.
9. de Man YA, Dolhain RJ, van de Geijn FE, Willemsen SP, Hazes JM. Disease activity of rheumatoid arthritis during pregnancy: results from a nationwide prospective study. Arthritis Rheum 2008;59:1241-8.
10. de Man YA, Bakker-Jonges LE, Goorbergh CM et al. Women with rheumatoid arthritis negative for anti-cyclic citrullinated peptide and rheumatoid factor are more likely to improve during pregnancy, whereas in autoantibody-positive women autoantibody levels are not influenced by pregnancy. Ann Rheum Dis 2010;69:420-3.
11. Ostensen M. The effect of pregnancy on ankylosing spondylitis, psoriatic arthritis, and juvenile rheumatoid arthritis. Am J Reprod Immunol 1992;28:235-7.
12. Lin HC, Chen SF, Chen YH. Increased risk of adverse pregnancy outcomes in women with rheumatoid arthritis: a nationwide population-based study. Ann Rheum Dis 2010;69:715-7.
13. Steen VD. Pregnancy in scleroderma. Rheum Dis Clin N Am 2007;33:345-58, vii.
14. Ruiz-Irastorza G, Crowther M, Branch W, Khamashta MA. Antiphospholipid syndrome. Lancet 2010;376:1498-509.
15. Lockshin MD, Kim M, Laskin CA et al. Prediction of adverse pregnancy outcome by the presence of lupus anticoagulant, but not anticardiolipin antibody, in patients with antiphospholipid antibodies. Arthritis Rheum 2012;64:2311-8.
16. Izmirly PM, Rivera TL, Buyon JP. Neonatal lupus syndromes. Rheum Dis Clin N Am 2007;33:267-85.
17. Eliasson H, Sonesson SE, Sharland G et al. Isolated atrioventricular block in the fetus: a retrospective, multinational, multicentre study of 175 patients. Circulation 2011;124:1919-26.
18. Izmirly PM, Costedoat-Chalumeau N, Pisoni C et al. Maternal use of hydroxychloroquine is associated with a reduced risk of recurrent anti-SSA/Ro associated cardiac manifestations of neonatal lupus. Circulation 2012;126:76-82.
19. Seo P. Pregnancy and vasculitis. Rheum Dis Clin N Am 2007;33:299-317.
20. Gatto M, Iaccarino L, Canova M et al. Pregnancy and vasculitis: a systematic review. Autoimmun Rev 2012;11:A447-59.
21. Martineau M, Haskard DO, Nelson-Piercy C. Behçet's syndrome in pregnancy. Obstet Med 2010;3:2-7.
22. Østensen M, Khamashta MA, Lockshin M et al. Anti-inflammatory and immunosuppressive drugs and reproduction. Arthritis Res Ther 2006;8:209-27.
23. Bramham K, Chusney G, Lee J, Lightstone L, Nelson-Piercy C. Breastfeeding and tacrolimus. Serial monitoring in breast and bottle fed infants. Clin J Am Soc Nephrol 2013;8:563-7.
24. Marchioni RM, Lichtenstein GR. Tumor necrosis factor-a inhibitor therapy and fetal risk: a systematic review. World J Gastroenterol 2013;19:2591-602.
25. Chakravarty EF, Murray ER, Kelman A, Farmer P. Pregnancy outcomes after maternal exposure to rituximab. Blood 2011;117:1499-506.
26. Royal College of Obstetrician and Gynaecologists. Thrombosis and embolism during pregnancy and the puerperium, reducing the risk (green-top 37a). London: RCOG, 2009.
27. Roberge S, Giguere Y, Villa P et al. Early administration of low-dose aspirin for the prevention of severe and mild preeclampsia: a systematic review and meta-analysis. Am J Perinatol 2012;29:551-6.
28. Roberge S, Nicolaides KH, Demers S, Villa P, Bujold E. Prevention of perinatal death and adverse perinatal outcome using low-dose aspirin: a meta-analysis. Ultrasound Obstet Gynaecol 2013;41:491-9.
29. Ayala DE, Ucieda R, Hermida RC. Chronotherapy with low-dose aspirin for prevention of complications in pregnancy. Chronobiol Int. 2013;30:260-79.
30. Soh MC, Pasupathy D, Gray G, Nelson-Piercy C. Persistent antiphospholipid antibodies do not contribute to adverse pregnancy outcomes. J Rheumatol 2013;52:1642-7.
31. Hofmeyr GJ, Lawrie TA, Atallah AN, Duley L. Calcium supplementation during pregnancy for preventing hypertensive disorders and related problems. Cochrane Database Syst Rev 2010;(8):CD001059.